1201187-44-1Relevant articles and documents
IRAK4 kinase inhibitor and preparation method thereof
-
, (2021/02/05)
The present invention provides a compound represented by a general formula I, and a pharmaceutically acceptable salt, a stereoisomer, an ester, a prodrug, a solvate and a deuterated compound thereof,and the compound is an IRAK4 kinase inhibitor, and can be used for prevention and/or treatment of IRAK4 related diseases, such as autoimmune diseases, inflammatory diseases, cancers, heteroimmune diseases, thromboembolism, atherosclerosis, myocardial infarction and metabolic syndrome.
Preparation of (5 - tosyl - 555H-pyrrolo [2, 3 - b] pyrazine -2 -yl) carbamic acid tert-butyl ester (by machine translation)
-
, (2019/09/14)
The present invention relates to (5 - tosyl - 555H-pyrrolo [2. The preparation method comprises the following steps: 3 - b,2 - diamine as a starting raw material, synthesizing (-2, 5 -] pyrazino 5 -yl) carbamic acid tert-butyl ester through a series of re
Influenza virus replication inhibitors and uses thereof (by machine translation)
-
, (2019/10/01)
The invention provides a compound as an influenza virus replication inhibitor, a method for preparing the same, a pharmaceutical composition containing the compound and application. (by machine translation)